Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Biorxiv : the Preprint Server for Biology|July 10, 2023
Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpointsAlexa C Cannon, Konstantin Budagyan, Cristina Uribe-Alvarez, et al.
Oncogene|January 19, 2024
Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpointsAlexa C Cannon, Konstantin Budagyan, Cristina Uribe-Alvarez, et al.
Breast Cancer Research and Treatment|June 30, 2019
Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancerVladislav Korobeynikov, Michelle Borakove, Yayi Feng, et al.
Oncotarget|October 15, 2016
Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibitionOlga Villamar Cruz, Tatiana Y Prudnikova, Daniela Araiza-Olivera, et al.
Nucleic Acids Research|September 22, 2023
The TRIM69-MST2 signaling axis regulates centrosome dynamics and chromosome segregationYilin Wang, Patrik Risteski, Yang Yang, et al.
Cell|May 22, 2003
Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinaseWang L Cheung, Kozo Ajiro, Kumiko Samejima, et al.
Oncotarget|January 19, 2015
Group I Paks as therapeutic targets in NF2-deficient meningiomaHoi-Yee Chow, Biao Dong, Sergio G Duron, et al.
Plos One|September 11, 2013
p21-Activated kinase (PAK) regulates cytoskeletal reorganization and directional migration in human neutrophilsAsako Itakura, Joseph E Aslan, Branden T Kusanto, et al.
The Journal of Cell Biology|July 7, 2010
Arpc1b, a centrosomal protein, is both an activator and substrate of Aurora APoonam R Molli, Da-Qiang Li, Rozita Bagheri-Yarmand, et al.
Blood|April 1, 2015
Pak2 restrains endomitosis during megakaryopoiesis and alters cytoskeleton organizationRachelle E Kosoff, Joseph E Aslan, John C Kostyak, et al.
Pageof 17